Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Nuseed Nutritional US Inc. focuses its patent efforts within the Biotechnology & Pharmaceuticals technology area. The company currently manages 2 pending office actions. These actions are split across 2 distinct art units, indicating that the company's nutritional and biological innovations are being reviewed by different specialized groups within the patent office. This distribution suggests a range of technical applications that require navigation of different examination standards.
The prosecution involves a distinct examiner for each matter. RADOSAVLJEVIC, ALEKSANDAR is identified as the busiest examiner, with 1 busiest examiner pending action. This means that RADOSAVLJEVIC, ALEKSANDAR is responsible for a portion of the company's current pending office actions. The company must manage multiple examiner relationships simultaneously, as no single examiner or art unit dominates the current prosecution landscape for this portfolio. This distribution requires the company to maintain prosecution strategies tailored to the specific requirements of each examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (50%) |
| No statute on record | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RADOSAVLJEVIC, ALEKSANDAR | 1 | 81.7% | +8.7% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.3% | +38.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18821276 | GENETICALLY ENGINEERED LAND PLANTS THAT EXPRESS AN INCREASED SEED YIELD PROTEIN AND/OR AN INCREASED SEED YIELD RNA | RADOSAVLJEVIC, ALEKSANDAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17049006 | DHA ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 67d overdue |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18821276 | GENETICALLY ENGINEERED LAND PLANTS THAT EXPRESS AN INCREASED SEED YIELD PROTEIN AND/OR AN INCREASED SEED YIELD RNA | RADOSAVLJEVIC, ALEKSANDAR | 1662 | DP | Non-Final OA | — | Pending | Aug 30, 2024 |
| 17049006 | DHA ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | — | Final Rejection | 67d overdue | Pending | Oct 19, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial